地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172469628
传真:13212737804
邮箱:sales@amyjet.com
艾美捷科技有限公司代理Kingfisher Biotech公司产品,详见:
http://www.amyjet.com/Index/lists/catid/27/kid/51.html
Kingfisher Biotech致力于兽医学研究和人类疾病的动物模型,涵盖的物种包括:牛、狗、马、鸡、海豚、猫、猪、仓鼠、小鼠、兔子、大鼠、火鸡等等。目前,Kingfisher Biotech的产品线中有查过1200种重组蛋白、多抗、单抗和ELISA试剂盒,能够为全世界动物保健和动物模型客户提供优质的产品。
Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors.
Kingfisher Biotech公司产品涉及的物种包括:
Bovine、Canine、Caprine、Catfish、Chicken、Dolphin、Equine、Feline、Ferret、Guinea Pig、Hamster、Human、Llama、Monkey、Mouse、Ovine、Rabbit、Rat、Salmon、Swine、Turkey、Zebrafish
| 产品列表 |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1675A-025) |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1675A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1676A-100) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1676A-025) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1676A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1676A-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| Cynomolgus Monkey CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1692Y-003) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1644AP-025) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1644AP-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 alpha (IL-1F1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0667B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Human APRIL (TNFSF13) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0292H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1085H-100) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1085H-025) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1085H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1085H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human CCL21 (6Ckine) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1512H-005) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1531H-025) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1531H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1657GP-100) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1657GP-025) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1657GP-005) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1657GP-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0754D-100) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0754D-025) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0754D-005) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0754D-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0085D-100) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0085D-025) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0085D-005) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0085D-500) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0920D-100) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0920D-025) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0920D-005) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0920D-500) |
| Canine IL-25 (IL-17E) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1697D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Catfish IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0439CF-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Llama ACT1 Activation Monoclonal Antibody (clone LH9A) (Kingfisher, CAT#WS0813L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LH7A) (Kingfisher, CAT#WS0812L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LT78A) (Kingfisher, CAT#WS0823L-100) |
| Llama CD2 or CD6 predicted Monoclonal Antibody (clone LH43A) (Kingfisher, CAT#WS0815L-100) |
| Llama CD2 or CD6 Predicted Monoclonal Antibody (clone LT10A) (Kingfisher, CAT#WS0819L-100) |
| Llama CD44 Monoclonal Antibody (clone LT36A) (Kingfisher, CAT#WS0821L-100) |
| Llama CD45 Predicted Monoclonal Antibody (clone LT12A) (Kingfisher, CAT#WS0820L-100) |
| Llama CD5 Predicted Monoclonal Antibody (clone LT3A) (Kingfisher, CAT#WS0817L-100) |
| Llama CD8 Monoclonal Antibody (clone LT5A) (Kingfisher, CAT#WS0818L-100) |
| Llama MHC II Monoclonal Antibody (clone LT1A) (Kingfisher, CAT#WS0816L-100) |
| Llama Pan B cell Monoclonal Antibody (clone LH41A) (Kingfisher, CAT#WS0814L-100) |
| Llama Pan T cell Monoclonal Antibody (clone LT97A) (Kingfisher, CAT#WS0824L-100) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1031Y-100) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1031Y-025) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1031Y-005) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1031Y-500) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1321Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1321Y-025) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1321Y-005) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1321Y-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody (Kingfisher, CAT#KP1669Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1670Y-050) |
| Cynomolgus Monkey IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1671Y-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody (Kingfisher, CAT#KP1694D-100) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1695D-050) |
| Canine BAFF (TNFSF13B) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1696D-003) |
| Canine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0891D-003) |
| Canine Fas Ligand (FasL) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1288D-003) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1647CT-100) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1647CT-025) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1647CT-005) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1647CT-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0665B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Bovine TNF alpha (TNFSF2) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0675B-003) |
| Bovine VEGF-A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0676B-003) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL2 (MCP-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0659B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0003E-100) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0003E-025) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0003E-005) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0003E-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Zebra Finch SCF (Stem Cell Factor) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1579ZN-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0013B-100) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0013B-025) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0013B-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0013B-500) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0311B-100) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0311B-025) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0311B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0311B-500) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技有限公司代理Mimotopes公司多肽及多肽合成相关产品。Mimotopes公司位于澳大利亚,可以提供2000余种多肽,100余种药物及化妆品肽,1000余种各类氨基酸及多肽合成用试剂。
Mimotopes公司的主要产品类别:
(1)多肽(Peptides)
库存普通多肽(Catalogue Peptides)
化妆品肽(Cosmetic Peptides)
药物肽(Pharmaceutical Peptides)
肽库(Off-the-Shelf Library)
(2)氨基酸(Amino Acids)
Z Amino Acids
Unusual Amino Acids
N methyl Amino Acids
Fmoc Amino Acids
Common Amino Acids
Boc amino acids
AA attached_to_2-Chlorotrityl_Resin
AA attached_to_Wang_Resin
(3)多肽合成试剂(Peptides Synthesis Reagents)
Coupling Reagents
Amino Alcohols
General Reagents
Linkers
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Mimotopes"> Mimotopes
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

艾美捷科技代理OV (Ohio Valley Specialty Company) 品牌全系列产品。

OV (Ohio Valley Specialty)(俄亥俄特殊化学品公司)位于Ohio州Marietta,专注于气相色谱相关产品。
主要产品包括:
气相色谱柱填料
气相色谱固定相
固体载体
硅烷化试剂
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Ohio Valley Specialty Company (OVSC)"> Ohio Valley Specialty Company (OVSC)
Diapharma Group INC成立于1997年,研究人员具有多年临床以及研发经验,专注于血液病领域的试剂盒,试剂以及仪器,主要涵盖血栓形成、止血、血小板功能分析、细胞凋亡、生态毒理学等。"
Diapharma Group, Inc. in West Chester, Ohio sells hemostasis, thrombosis, platelet function testing, instrumentation, and apoptosis products in the diagnostic and research fields and provides strong technical competence and experience to ensure customer expectations will be met or exceeded.
DiaPharma Group的主要产品包括:
CK18 Biomarkers & Others
Apoptosis & Necrosis
Toxicology
Oncology
Hepatology
Hemostasis
Chromogenic Substrates
Coagulation Kits
Anticoagulation Monitoring Kits
Fibrinolysis Kits
Hemostasis Autoimmunity
Calibrators & Controls
Enzymes & Other Proteins
Buffers & Diluents
Factor Deficient Plasmas
Inhibitor Plasmas
Phospholipids
Antibodies
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="diapharma"> diapharma

美国国家标准与技术研究院(National Institute of Standards and Technology,NIST),从事物理、生物和工程方面的基础和应用研究,以及测量技术和测试方法方面的研究,提供标准、标准参考数据及有关服务,在国际上享有声誉。
The National Institute of Standards and Technology (NIST) is a physical sciences laboratory, and a non-regulatory agency of the United States Department of Commerce. Its mission is to promote innovation and industrial competitiveness. NIST's activities are organized into laboratory programs that include nanoscale science and technology, engineering, information technology, neutron research, material measurement, and physical measurement.
NIST的主要产品和服务包括:
(1)STANDARDS AND MEASUREMENTS
Calibration Services
Laboratory Accreditation (NVLAP)
Quality System
Standard Reference Materials (SRMs)
Standards.gov
Time Services
Office of Weights and Measures
(2)SOFTWARE
(3)DATA
Chemistry WebBook
National Vulnerability Database
Physical Reference Data
Standard Reference Data (SRD)
(4)COMPUTER SECURITY RESOURCE CENTER (CSRC)
(5)LICENSE & PATENTS
(6)NIST RESEARCH LIBRARY
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷代理全系列LGC Maine Standards线性校准品。
Maine Standards公司独有的VALIDATE®即用型试剂,可以帮助检验机构对要求的线性、校准和线性范围进行验证。
VALIDATE® ready-to-use kits are designed to assist in the documentation of linearity, calibration verification and verification of linear range required by many inspection agencies. VALIDATE® will also provide assistance when troubleshooting instrument systems, reagent problems and calibration anomalies. Multiple product configurations are available to meet the different needs of the many instrument systems available. Configurations are specifically formulated to maximize reportable ranges with minimum dilutions.
产品系列包括:VALIDATE® GC、VALIDATE® PCT、VALIDATE® Body Fluids、VALIDATE® IBC、VALIDATE® LP、VALIDATE® HbA1c、VALIDATE® TDM、VALIDATE® UC、VALIDATE® SP、VALIDATE® THY、VALIDATE® CM、VALIDATE® Anemia、VALIDATE® Fertility、VALIDATE® Tumor Markers、VALIDATE® VIT D、VALIDATE® OSMO、VALIDATE® WBG、VALIDATE® Hemostasis。

更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
产品列表及详情也可访问艾美捷科技丁香通商城:
https://vicbio.biomart.cn/supply/c_271529.htm






Diarect有着20多年自身抗原研发经验的Liedvogel教授和Hanbruck博士联手创建。1993年Haubruck博士利用杆状病毒/Sf9昆虫细胞表达系统成功的研发出人重组抗原--TPO,6年后Diarect是第一家将人重组TPO引进体外诊断市场的公司。
Established in 1998, DIARECT AG is a privately owned biotech company with expertise in developing and establishing standardized large-scale productions of both recombinant and native proteins, including their worldwide distribution. Providing customers with products and services of consistent quality is one of the cornerstones of DIARECT’s business philosophy.
DIARECT is not only a leading manufacturer of autoimmune and infectious disease antigens, but also of recombinant allergens. In additon, DIARECT is the exclusive distributor of Surmodics in Europe. With Surmodics' protein stabilization reagents, blockers and BioFX substrates, DIARECT is able to provide most of the critical components for the development of diagnostic end products.
Diarect公司的主要产品包括:
Allergens
Autoimmune Disease Antigens
Infectious Disease Antigens
Antigen FAQ
Selected References
Protein Stabilizers / Blockers
Immunoassay Stabilizers
Protein and Conjugate Stabilizers
Microsphere and Microarray Stabilizers
StabilBlot™ Blockers
Protein Stabilizers / Blockers FAQ
Selected References
Immunoassay Substrates
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Diarect"> Diarect
艾美捷科技代理Nordic MUbio品牌产品。
Nordic-MUbio公司为生物医学和兽医研究提供2000多种基本免疫试剂,包括抗血清、抗体、免疫偶联物、纯化蛋白、对照品、血清蛋白标准品和其他校准品。它们包括高度特异性的单克隆抗体,以及用于不同测试系统的偶联二抗试剂。Nordic-MUbio专注于免疫学,拥有超过1700种针对人、小鼠、猴子和大鼠免疫球蛋白类及其亚类的特异性抗血清。此外还有针对不同动物物种的其他血清蛋白多克隆抗血清和针对酶的多克隆抗血清。Nordic-MUbio的抗体也以荧光和辣根过氧化物酶偶联物的形式提供。
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Nordic MUbio品牌产品"> 艾美捷科技代理Nordic MUbio品牌产品
DiaMetra公司位于意大利Perugia,致力于为诊断行业提供高品质产品,包括标品和检测试剂盒,涉及的检测领域包括:唾液试剂盒、高血压及钙的代谢、自体免疫疾病、糖尿病指标检测、肿瘤标志物、固醇类激素、性激素、甲状腺激素检测等。
Diametra is dedicated to providing quality products and the highest level of service in its target diagnostics segments. Through innovation and total commitment we strive to create value for our people, our customers and for the shareholders.
As an organization we constantly strive for innovation, not simply in the products we bring to the market but also in the way we interact with our customers and with each other. This is grounded in our solution driven approach to partnership.
产品主要应用领域:
Saliva kits
Hypertension / Calcium Metabolism
Controls
Autoimmune Diseases
Diabetes Monitoring
Tumor Markers
Steroids Hormones
Fertility Proteic Hormones
Thyroid Monitoring
Circulating Immuno Complexes
Miscellaneous
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:18372041646
邮箱:sales@amyjet.com
0.359